Co-chairs the Life Sciences group. Focuses practice on FDA regulation of pharmaceuticals, biologics, and medical devices. Expertise covers all phases of product life cycle, from initial regulatory strategy development through postmarket compliance. Frequently helps clients establish compliance programs and procedures to address the complex laws and regulations under which life sciences companies operate, assists clients with internal and government compliance investigations, and represents clients in enforcement actions and other matters before the FDA. Frequent lecturer and author on FDA regulatory issues.
BA, magna cum laude, Brown University 1990; JD, magna cum laude, Georgetown University Law Center, 1996.